Bausch + Lomb (NYSE:BLCO) received US FDA clearance for its Bi-Blade+ dual-port vitrectomy cutter and Adaptive Fluidics update, expanding its retina surgery toolkit. The company launched the enVista ...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has ...
Hello, Dear Readers! Just a quick update to let you know that my eye surgery (a vitrectomy for vitreomacular traction) took ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results